Are Wall Street Analysts Bullish on Boston Scientific Stock?

Boston Scientific Corporation (BSX), a Massachusetts-based company with a market cap of $123.1 billion, is a leader in the medical devices sector. Specializing in interventional medical specialties, it designs, manufactures, and distributes a broad range of products worldwide across cardiovascular, neuro, rhythm, and MedSurg specialties.

Shares of the leading medical device company have outperformed the broader market over the past 52 weeks. BSX has gained 61.9% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 35.2%. In 2024 alone, shares of BSX are up 44.7%, compared to SPX's 20.1% gains on a YTD basis.